Multiple sclerosis in Levothyroxine sodium - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Multiple sclerosis, when it was recovered, drug effectiveness, race, and more among people who take Levothyroxine sodium (levothyroxine sodium). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,813 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,085 drugs and 1,365 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jun, 03, 2026

17 people who have Multiple sclerosis while taking Levothyroxine sodium were studied.

Could Levothyroxine sodium cause Multiple sclerosis?

Severity of Multiple sclerosis *:

least: 18.18 %
moderate: 63.64 %
severe: 18.18 %
most severe: 0.0 %

When people recovered from Multiple sclerosis *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Levothyroxine sodium *:

not at all: 0.0 %
somewhat: 8.33 %
moderate: 33.33 %
high: 33.33 %
very high: 25.0 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 15.38 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 84.62 %

Time on Levothyroxine sodium *:

Gender of people when taking Levothyroxine sodium *:

female: 100 %
male: 0.0 %

Age of people when taking Levothyroxine sodium *:

Conditions people have *:

Pain: 6 people, 35.29%
Depression: 6 people, 35.29%
Stress And Anxiety: 5 people, 29.41%
High Blood Cholesterol: 5 people, 29.41%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 23.53%
Migraine (headache): 4 people, 23.53%
High Blood Pressure: 3 people, 17.65%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 17.65%
Blood Clots: 3 people, 17.65%
Asthma: 2 people, 11.76%

Other drugs people take besides Levothyroxine sodium *:

Other side effects people have besides Multiple sclerosis *:

Migraine (headache): 4 people, 23.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 17.65%
Stress And Anxiety: 2 people, 11.76%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 2 people, 11.76%
Irritable Bowel Syndrome: 2 people, 11.76%
Weight Increased: 1 person, 5.88%
Depression: 1 person, 5.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.88%
Fatty Liver: 1 person, 5.88%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and have Multiple sclerosis?

Check whether Multiple sclerosis is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Multiple sclerosis in Levothyroxine sodium

How the study uses the data?

The study is based on levothyroxine sodium (the active ingredients of Levothyroxine sodium). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.